Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2001

View Archived Issues

Somatostatin analogue as a potential DMARD for patients with RA

ImClone Systems reports update on major products

Demegen and Dow to design new compounds

Biopure's Hemopure reaches clinical milestone

Wyeth-Ayerst notifies health professionals of safety information for Neumega

Tranzyme establishes collaboration with NeoGenesis

Drug abuse treatment subject of SBIR grant awarded to Albany Molecular Research

Biovail seeks FDA approval of Cardizem XL

Salix acquires rights to Colazal for Japan, Korea and Taiwan

Servier describes its novel dopamine D3 receptor agonist S-32504

Q2 at NeoTherapeutics marked by milestone achievements

Scientists at Queen Mary and Medivir to collaborate in identifying protease drug targets

Biovation and Micromet sign research agreement

FDA issues draft guidance to further reduce the possible risk of transmission of vCJD by blood

Research collaboration announced between Janssen and Biofrontera

Salus awarded grant to develop MS drug discovery program

ACAT inhibitor F-1394 found to act directly on the arterial wall

More information on the beneficial effects of resveratrol

Broad-spectrum antibacterials reported by Pharmacia

Selective GABA-A alpha5 ligands reported by Merck

Sumitomo claims compounds useful for neuroretinal degenerative diseases

Neuropeptide Y antagonists designed at Fujisawa

Sanofi-Synthelabo discloses PDE5 inhibitors and their use

Alcon presents potential antiglaucoma 13-oxaprostaglandins at the ACS meeting

Mitsubishi highlights their anti-H. pylori candidate at the ACS meeting

Uriach identifies UR-8880, its lead COX-2 inhibitor as a preclinical candidate

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...